Assignee
RESPIRA THERAPEUTICS INC
US12 patents
Top patents by PatentIndex Score
US10912778B2Feb 9, 2021
Methods for treatment of pulmonary hypertension
RESPIRA THERAPEUTICS INC10 citations82
US10463815B2Nov 5, 2019
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
RESPIRA THERAPEUTICS INC3 citations71
US10525216B2Jan 7, 2020
Powder dispersion methods and devices
RESPIRA THERAPEUTICS INC3 citations70
US11471623B2Oct 18, 2022
Powder dispersion methods and devices
RESPIRA THERAPEUTICS INC0 citations60
US10682476B2Jun 16, 2020
Powder inhaler, system and methods
RESPIRA THERAPEUTICS INC1 citations60
US12364701B2Jul 22, 2025
PDE5 inhibitor powder formulations and methods relating thereto
RESPIRA THERAPEUTICS INC0 citations59
US12263174B2Apr 1, 2025
Methods and compositions for treatment of pulmonary hypertension and other lung disorders
RESPIRA THERAPEUTICS INC0 citations59
US11911390B2Feb 27, 2024
PDE5 inhibitor powder formulations and methods relating thereto
RESPIRA THERAPEUTICS INC0 citations59
US11806314B2Nov 7, 2023
PDE5 inhibitor powder formulations and methods relating thereto
RESPIRA THERAPEUTICS INC0 citations59
US11491160B2Nov 8, 2022
Methods and compositions for treatment of pulmonary hypertension and other lung disorders
RESPIRA THERAPEUTICS INC0 citations59
US11491161B2Nov 8, 2022
Methods and compositions for treatment of pulmonary hypertension and other lung disorders
RESPIRA THERAPEUTICS INC0 citations59
US10441733B2Oct 15, 2019
Powder dispersion devices and methods
RESPIRA THERAPEUTICS INC0 citations49